ScholarIQanswers from OpenAlex
Mount Vernon Cancer Centre
InstitutionResearch output, impact & collaborations
Mount Vernon Cancer Centre is a institution indexed in ScholarIQ from OpenAlex.
What is known about Mount Vernon Cancer Centre?
ScholarIQrecord summary
Mount Vernon Cancer Centre is a research organisation in Northwood, GB. OpenAlex records 2,463 works and 193,219 citations for it. 393 researchers list it as their most recent affiliation.
How many works does Mount Vernon Cancer Centre have?
ScholarIQindexed works
Mount Vernon Cancer Centre has 2,463 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Mount Vernon Cancer Centre have?
ScholarIQcitation count
Mount Vernon Cancer Centre has 193,219 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Mount Vernon Cancer Centre?
ScholarIQresearcher count
Mount Vernon Cancer Centre has 393 researchers in the ScholarIQ index.
What is the average h-index at Mount Vernon Cancer Centre?
ScholarIQavg h-index
Mount Vernon Cancer Centre has an average h-index of 81.7 in OpenAlex.
What is the ROR of Mount Vernon Cancer Centre?
ScholarIQror
The ROR for Mount Vernon Cancer Centre is on the source record.
What is the OpenAlex record for Mount Vernon Cancer Centre?
ScholarIQopenalex
The OpenAlex for Mount Vernon Cancer Centre is on the source record.
Who are the most-cited researchers behind Mount Vernon Cancer Centre?
ScholarIQtop researchers by citations
What are the most-cited papers on Mount Vernon Cancer Centre?
ScholarIQmost cited works
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
Jonathan A. Ledermann, Philipp Harter, Charlie Gourley, Michael Friedländer, Ignace Vergote, Gordon Rustin, Clare L. Scott, Werner Meier, Ronnie Shapira‐Frommer, Tamar Safra, Daniela Matei, Euan Macpherson, Claire Watkins, James Carmichael, Ursula A. Matulonis
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
Amit M. Oza, Adrian Cook, Jacobus Pfisterer, Andrew Embleton-Thirsk, Jonathan A. Ledermann, Éric Pujade-Lauraine, Gunnar B. Kristensen, Mark S. Carey, Philip Beale, Andrés Cervantes, Tjoung‐Won Park‐Simon, Gordon Rustin, Florence Joly, Mansoor Raza Mirza, Marie Plante, Michael Quinn, Andrés Poveda, Gordon C. Jayson, Dan Stark, Ann Marie Swart, Laura Farrelly, Richard Kaplan, Mahesh Parmar, Timothy Perren
The Lancet Commission on prostate cancer: planning for the surge in cases
Nicholas D. James, Ian F. Tannock, James N’Dow, Felix Y. Feng, Silke Gillessen, Syed Adnan Ali, Blanca Trujillo, Bissan Al‐Lazikani, Gerhardt Attard, Freddie Bray, Éva Compérat, Rosalind A. Eeles, Omolara Fatiregun, Emily Grist, Susan Halabi, Áine Haran, Daniel Herchenhorn, Michael S. Hofman, Mohamed Jalloh, Stacy Loeb, Archie Macnair, Brandon A. Mahal, Larissa Mendes, Masood Moghul, Caroline M. Moore, Alicia K. Morgans, Michael J. Morris, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, Anwar R. Padhani, Charles Parker, Hannah Rush, Mark Sculpher, Howard R. Soule, Matthew R. Sydes, Derya Tilki, Nina Tunariu, Paul Villanti, Liping Xie
Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline
Jeanin E. van Hooft, Emo E. van Halsema, Geoffroy Vanbiervliet, Regina G. H. Beets‐Tan, John M. DeWitt, Fergal Donnellan, Jean‐Marc Dumonceau, Rob Glynne‐Jones, Cesare Hassan, Javier Jiménez-Pérez, Søren Meisner, V. Raman Muthusamy, Mike Parker, Jean‐Marc Regimbeau, Charles Sabbagh, Jayesh Sagar, Pieter J. Tanis, Jo Vandervoort, George Webster, Gianpiero Manes, Marc Barthet, Alessandro Repici
Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline
Jeanin E. van Hooft, Emo van Halsema, Geoffroy Vanbiervliet, Regina G. H. Beets‐Tan, John M. DeWitt, Fergal Donnellan, Jean‐Marc Dumonceau, Rob Glynne‐Jones, Cesare Hassan, Javier Jiménez-Pérez, Søren Meisner, Vignesh Muthusamy, Mike Parker, Jean‐Marc Regimbeau, Charles Sabbagh, Jayesh Sagar, Pieter J. Tanis, Jo Vandervoort, George Webster, Gianpiero Manes, Marc Barthet, Alessandro Repici
How much of the research on Mount Vernon Cancer Centre is open access?
ScholarIQopen access share
63%OPEN ACCESS